(AOF) – Geneuro, a biopharmaceutical company, has appointed Anke Post as Chief Medical Officer, following the retirement of David Leppert, Medical Director since April 2020. Anke Post will bring her extensive academic and medical experience to the field of neuroscience, psychiatry and neurology, as well as extensive experience in the pharmaceutical industry. She has worked for 25 years developing drugs for psychiatric and neurodegenerative diseases, including ALS.
She brings her drug development experience to all phases of development, including leading teams on international projects, contract research organizations, and managing interactions with regulatory authorities.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
